Peer-reviewedCC BYFrontiers in medicine
Yiguanjian alleviates ocular surface inflammation and lacrimal gland immune dysregulation in experimental dry eye disease: evidence from in vivo and in vitro models
- 1The First Hospital of Hunan University of Chinese Medicine , ,
- 2Hunan University of Chinese Medicine , ,
Related
- Dihydroartemisinin alleviates allergic airway inflammation by suppressing the PI3K-AKT signaling axis: integrated network pharmacology and experimental validation.
- Commentary: Wogonoside alleviates metabolic dysfunction-associated steatohepatitis by modulating AMPK and xCT/GPX4 pathways to restrain lipid dysregulation and ferroptosis
- P2226 alleviates respiratory inflammation and depression related behaviors with modulation of cytokines and gut microbiota in mice
- Re-Du-Ning Alleviates Airway-Intestinal Inflammation of COPD Rats by Regulating Glycerophospholipid Metabolism and Modulating Gut Microbiome
- Lipid Dysregulation and Impaired Resolution of Inflammation in Genetic Forms of Parkinson’s Disease: Potential Links and Knowledge Gaps
BibTeX
@article{zhong2026yiguanjian,
title = {{Yiguanjian alleviates ocular surface inflammation and lacrimal gland immune dysregulation in experimental dry eye disease: evidence from in vivo and in vitro models}},
author = {Yuan Zhong and Jian Shi and Xiyuan Liu and Yanwen Zhang and Qinghua Peng and Jun Peng},
journal = {Frontiers in medicine},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13654703},
note = {CC BY},
}
RIS
TY - JOUR
TI - Yiguanjian alleviates ocular surface inflammation and lacrimal gland immune dysregulation in experimental dry eye disease: evidence from in vivo and in vitro models
AU - Yuan Zhong
AU - Jian Shi
AU - Xiyuan Liu
AU - Yanwen Zhang
AU - Qinghua Peng
AU - Jun Peng
PY - 2026
DA - 2026/10/16
JO - Frontiers in medicine
UR - https://europepmc.org/article/PMC/PMC13654703
SN - 2296-858X
ER -